148 related articles for article (PubMed ID: 38622340)
1. Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression.
Watanabe K; Tasaka K; Ogata H; Kato S; Ueno H; Umeda K; Isobe T; Kubota Y; Sekiguchi M; Kimura S; Sato-Otsubo A; Hiwatari M; Ushiku T; Kato M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Gene Ther; 2024 Apr; ():. PubMed ID: 38622340
[TBL] [Abstract][Full Text] [Related]
2. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
[TBL] [Abstract][Full Text] [Related]
3. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.
Khiaowichit J; Talabnin C; Dechsukhum C; Silsirivanit A; Talabnin K
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207462
[TBL] [Abstract][Full Text] [Related]
5. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
6. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
[TBL] [Abstract][Full Text] [Related]
7. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism for C1GALT1 in the regulation of gastric cancer progression.
Dong X; Chen C; Deng X; Liu Y; Duan Q; Peng Z; Luo Z; Shen L
Cell Biosci; 2021 Aug; 11(1):166. PubMed ID: 34452648
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
10. C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.
Lin NY; Chen ST; Chang HL; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Huang MC; Chang HH
Oncogenesis; 2022 Feb; 11(1):8. PubMed ID: 35169131
[TBL] [Abstract][Full Text] [Related]
11. Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) as a Chemosensitivity-Related Biomarker for Osteosarcoma.
Xi Q; Ma J
J Oncol; 2023; 2023():1083423. PubMed ID: 38024474
[TBL] [Abstract][Full Text] [Related]
12. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
[TBL] [Abstract][Full Text] [Related]
13. C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
Dong X; Liu Y; Deng X; Shao J; Tian S; Chen S; Huang R; Lin Z; Chen C; Shen L
Front Cell Dev Biol; 2021; 9():707970. PubMed ID: 34307388
[TBL] [Abstract][Full Text] [Related]
14. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
[No Abstract] [Full Text] [Related]
15. Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8
Tang L; Cegang F; Zhao H; Wang B; Jia S; Chen H; Cai H
Curr Cancer Drug Targets; 2023; 23(4):265-277. PubMed ID: 36221889
[TBL] [Abstract][Full Text] [Related]
16. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
[TBL] [Abstract][Full Text] [Related]
17. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway.
Liu Y; Xi Y; Chen G; Wu X; He M
J Orthop Surg Res; 2020 Jun; 15(1):226. PubMed ID: 32552851
[TBL] [Abstract][Full Text] [Related]
18. C1GALT1 in health and disease.
Sun X; Zhan M; Sun X; Liu W; Meng X
Oncol Lett; 2021 Aug; 22(2):589. PubMed ID: 34149900
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
